Thu Mar 23, 2023 – 5:32 pm EDTThu Mar 23, 2023 – 5:35 pm EDT
WASHINGTON, D.C. (LifeSiteNews) – U.S. Sen. Rand Paul (R-KY) confronted Moderna CEO Stéphane Bancel Wednesday on the safety of his company’s mRNA-based COVID-19 vaccine, particularly mounting evidence linking the shot to increased risk of myocarditis.
The Daily Caller reports that during the Senate hearing, Paul asked, “is there a higher incidence of myocarditis among adolescent males ages 16-24 after taking your vaccine?” Bancel started a non-responsive answer but was cut off by Paul, who reiterated that he wanted a “yes or no.”
“The data … has shown there’s less [risk] for people who get the vaccine versus people who get the COVID infection,” he said.
“That is not true,” Paul responded, citing six research papers on the subject. “The fact that you can’t say it in public is quite disturbing. Do you think it’s scientifically sound to mandate three vaccines for adolescent boys?”
🚨🚨🚨
Dr. Rand Paul Grills Moderna CEO on COVID-19 Vaccines and Myocarditis pic.twitter.com/Sp1UBf8OOP
— Senator Rand Paul (@SenRandPaul) March 22, 2023
“I’ll ask you this question: your 16-year-old had COVID, your 16-year-old gets better and now has recovered
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
